Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

Phase 2

2(40.0%)

Phase 3

2(40.0%)

N/A

1(20.0%)

5Total

Phase 2(2)

Phase 3(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07524894Phase 2Not Yet Recruiting

Staph Nasal Decolonization to Improve Function and Feeding

Role: lead

NCT05986318Phase 2Recruiting

Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease

Role: lead

NCT07337161Not ApplicableRecruiting

Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma

Role: lead

NCT05717166Phase 3Recruiting

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.

Role: lead

NCT03721341Phase 3Active Not Recruiting

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors

Role: lead

NCT06156800Recruiting

Is Radiation-before-pathology a Feasible Approach in the Palliative Oncology Setting? A Pragmatic Clinical Trial

Role: lead

All 6 trials loaded